Drug Trial Radar · NCT07477691
Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
12
Planned (sponsor's estimate)
Start
May 29, 2026
Primary completion
Sep 30, 2027
Study completion Sep 30, 2027
Sponsor
- Lead sponsor
- BioMarin PharmaceuticalBioMarin (BMRN)
- Sponsor type
- Industry
- First posted
- Mar 17, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study 165-401 is a Phase 4, open-label study designed to examine the concomitant use of methotrexate (MTX) to suppress immune responses to Palynziq and improve tolerability and efficacy in adults with PKU.
Conditions
- Phenylketonuria
Interventions
PegvaliaseBiological
Pegvaliase (Palynziq) administered by subcutaneous injection. Dosing follows U.S. Prescribing Information and investigator judgement.
MethotrexateDrug
Oral methotrexate 15 mg administered once weekly during the Tolerability Period and the Combination Treatment Period.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in blood Phe levels from baseline to Week 25 and Week 49Time frame: Baseline to Week 25 and Baseline to Week 49
- Anti-PEG IgG, IgM, anti-PAL IgG, IgM levels at Weeks 5, 9, 25, and 49Time frame: Baseline to Week 5, Week 9, Week 25, and Week 49
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
UCLA Dept. of Human Genetics
Los Angeles, California · Recruiting
Children's Hospital Colorado
Aurora, Colorado · Recruiting
University Of South Florida Medical Center
Tampa, Florida · Recruiting
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois · Recruiting
Indiana University School of Medicine
Indianapolis, Indiana · Recruiting
University of Minnesota Medical School
Minneapolis, Minnesota · Recruiting
University of Rochester Medical Center (URMC)
Rochester, New York · Recruiting
Oregon Health & Science University (OHSU) - PARENT
Portland, Oregon · Recruiting
University of Pittsburgh Medical Center (UPMC) - Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania · Not yet recruiting
UT Southwestern Medical Center
Dallas, Texas · Recruiting
University of Utah Hospital
Salt Lake City, Utah · Not yet recruiting
Children's Hospital of Wisconsin
Milwaukee, Wisconsin · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.